Emergence of Secondary Acute Leukemia in a Patient Treated for Osteosarcoma: Implications of Germline TP53 Mutations

Medical and Pediatric Oncology

doi 10.1002/(sici)1096-911x(199803)30:3<165::aid-mpo7>3.0.co;2-f